NO164897C - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES. - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES.Info
- Publication number
- NO164897C NO164897C NO862439A NO862439A NO164897C NO 164897 C NO164897 C NO 164897C NO 862439 A NO862439 A NO 862439A NO 862439 A NO862439 A NO 862439A NO 164897 C NO164897 C NO 164897C
- Authority
- NO
- Norway
- Prior art keywords
- oxazolidinon
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
- F02B1/00—Engines characterised by fuel-air mixture compression
- F02B1/02—Engines characterised by fuel-air mixture compression with positive ignition
- F02B1/04—Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843438839 DE3438839A1 (en) | 1984-10-19 | 1984-10-19 | PHARMACEUTICAL PREPARATIONS |
PCT/DE1985/000472 WO1986002268A1 (en) | 1984-10-19 | 1985-10-18 | Pharmaceutical preparations |
Publications (4)
Publication Number | Publication Date |
---|---|
NO862439D0 NO862439D0 (en) | 1986-06-18 |
NO862439L NO862439L (en) | 1986-06-18 |
NO164897B NO164897B (en) | 1990-08-20 |
NO164897C true NO164897C (en) | 1990-11-28 |
Family
ID=6248597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO862439A NO164897C (en) | 1984-10-19 | 1986-06-18 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0198919B1 (en) |
JP (2) | JPH0742229B2 (en) |
AU (2) | AU5095885A (en) |
DE (2) | DE3438839A1 (en) |
DK (1) | DK167531B1 (en) |
FI (1) | FI862590A0 (en) |
NO (1) | NO164897C (en) |
WO (1) | WO1986002268A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783591A (en) * | 1984-10-19 | 1998-07-21 | Schering Aktiengesellschaft | Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation |
US4681940A (en) * | 1985-11-19 | 1987-07-21 | American Home Products Corporation | 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles |
DE3639225A1 (en) * | 1986-11-14 | 1988-05-19 | Schering Ag | USE OF 5- (SUBST. PHENYL) -OXAZOLIDINONE DERIATES AS PSYCHOPHARMAKA |
WO1988009661A1 (en) * | 1987-06-10 | 1988-12-15 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
ATE106243T1 (en) * | 1988-03-24 | 1994-06-15 | Sankyo Co | USE OF ISOXAZOLINONES AS CEREBRO-ACTIVE MEDICATIONS. |
US5420154A (en) * | 1990-08-03 | 1995-05-30 | Smithkline Beecham Corp. | TNF inhibitors |
US5124455A (en) * | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
US5547979A (en) * | 1992-03-30 | 1996-08-20 | Smithkline Beecham | TNF inhibition |
HUP9702408A3 (en) * | 1995-02-10 | 2000-08-28 | Schering Ag | Use of 5-phenyloxazolidin-2-one derivatives for the preparation of pharmaceutical compositions treating diseases requiring tumour necrosis factor (tnf) inhibition |
DE19540475A1 (en) * | 1995-10-20 | 1997-04-24 | Schering Ag | Chiral methylphenyloxazolidinones |
US6770658B2 (en) * | 1998-09-09 | 2004-08-03 | Inflazyme Pharmaceuticals Ltd. | Substituted γ-phenyl-Δ-lactams and uses related thereto |
DE60233884D1 (en) * | 2001-10-16 | 2009-11-12 | Memory Pharmaceutical Corp | 4 (4-ALKOXY-3-HYDROXYPHENYL) -2-PYRROLIDONE DERIVATIVES AS PDE-4 INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL SYNDROMES |
WO2004098592A1 (en) * | 2003-05-06 | 2004-11-18 | Senju Pharmaceutical Co. Ltd. | Composition containing oxazolidinone derivative |
AR057218A1 (en) | 2005-12-15 | 2007-11-21 | Astra Ab | OXAZOLIDINONE COMPOUNDS AND THEIR USE AS PONTENCIATORS OF THE METABOTROPIC GLUTAMATE RECEIVER |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2413935A1 (en) * | 1974-03-20 | 1975-10-16 | Schering Ag | 4- (POLYALCOXY-PHENYL) -2-PYRROLIDONE |
SU888821A3 (en) * | 1976-12-03 | 1981-12-07 | Шеринг Аг (Инофирма) | Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs |
DE2655369A1 (en) * | 1976-12-03 | 1978-06-08 | Schering Ag | 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION |
-
1984
- 1984-10-19 DE DE19843438839 patent/DE3438839A1/en not_active Withdrawn
-
1985
- 1985-10-18 WO PCT/DE1985/000472 patent/WO1986002268A1/en active IP Right Grant
- 1985-10-18 DE DE8585905773T patent/DE3576118D1/en not_active Expired - Lifetime
- 1985-10-18 AU AU50958/85A patent/AU5095885A/en not_active Abandoned
- 1985-10-18 JP JP60505152A patent/JPH0742229B2/en not_active Expired - Lifetime
- 1985-10-18 EP EP85905773A patent/EP0198919B1/en not_active Expired - Lifetime
-
1986
- 1986-06-17 FI FI862590A patent/FI862590A0/en not_active Application Discontinuation
- 1986-06-18 NO NO862439A patent/NO164897C/en unknown
- 1986-06-19 DK DK288686A patent/DK167531B1/en not_active IP Right Cessation
-
1990
- 1990-01-04 AU AU47653/90A patent/AU4765390A/en not_active Abandoned
-
1994
- 1994-02-04 JP JP6012897A patent/JP2669494B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO862439D0 (en) | 1986-06-18 |
JPH0761978A (en) | 1995-03-07 |
DK288686D0 (en) | 1986-06-19 |
AU5095885A (en) | 1986-05-02 |
JP2669494B2 (en) | 1997-10-27 |
NO164897B (en) | 1990-08-20 |
DE3576118D1 (en) | 1990-04-05 |
DK288686A (en) | 1986-06-19 |
FI862590A (en) | 1986-06-17 |
NO862439L (en) | 1986-06-18 |
JPS62501289A (en) | 1987-05-21 |
DE3438839A1 (en) | 1986-04-24 |
DK167531B1 (en) | 1993-11-15 |
EP0198919A1 (en) | 1986-10-29 |
AU4765390A (en) | 1990-05-03 |
WO1986002268A1 (en) | 1986-04-24 |
JPH0742229B2 (en) | 1995-05-10 |
FI862590A0 (en) | 1986-06-17 |
EP0198919B1 (en) | 1990-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO163406C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOKINOLINO DERIVATIVES. | |
NO167142C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLIC DERIVATIVES. | |
NO862477D0 (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-ARYLIMIDAZOLE DERIVATIVES. | |
NO864126D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDON DERIVATIVES. | |
NO853046L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOL DERIVATIVES. | |
NO871266D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES. | |
NO164165C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINOTETRALIN DERIVATIVES. | |
NO162514C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHILD DERIVATIVES. | |
NO167384C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N-ARALKYL PIPERIDINE-METHANOL DERIVATIVES. | |
NO870526D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DICHLORANILIN DERIVATIVES. | |
NO165239C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-BENZYL-AMINOALKYL-PYRROLIDINON DERIVATIVES. | |
NO165192C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE GLYCLE DERIVATIVES. | |
NO164097C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2- (N-SUBSTITUTED-GUANIDINO) -4-HETERO-ARYL-TIAZOL DERIVATIVES. | |
NO874032D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CATECHOLD DERIVATIVES. | |
NO152129C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OMEGA-CYAN-1, OMEGA-DIFENYL-AZAALKANDER DERIVATIVES | |
NO168355C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLD DERIVATIVES | |
NO161562C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ERGOLIN DERIVATIVES. | |
NO164897C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES. | |
NO161559C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRIAZOLD DERIVATIVES. | |
NO158941C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4-PIPERIDINO-CHINAZOLINE DERIVATIVES. | |
NO160079C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM DERIVATIVES. | |
NO862372D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLO DERIVATIVES. | |
NO165069C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOPENTYLETERS. | |
NO158739C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PIPERAZINOPYRIMIDINE DERIVATIVES. | |
NO161313C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORALLYLAMINE DERIVATIVES. |